Quarterly Vision Webinar – Age-Related Macular Degeneration (AMD)

Join the Foundation Fighting Blindness for an exclusive, deep-dive session into the breakthroughs that are changing the landscape of vision health.

The Future of AMD Research and Care

Age-related macular degeneration (AMD) impacts millions, but you don’t have to navigate the journey alone. Whether you are living with AMD, supporting a loved one as a caregiver, or a healthcare professional dedicated to patient sight, this webinar is designed specifically for you.

Why You Should Attend

We’re bringing together top experts to provide you with actionable insights and the latest scientific updates:

• AMD Decoded: Understand exactly how AMD affects the eye and what the latest diagnostic trends mean for you.
• The Cutting Edge: Get a first look at current clinical trials, emerging gene therapies, and potential new treatments on the horizon.
• Daily Success: Practical tips for managing vision loss and maintaining ocular health to improve quality of life.
• Ask the Experts: A live Q&A session where your most pressing questions get answered in real-time.

Meet our Panelists 

Our panel combines foundational science, surgical mastery, and cutting-edge regenerative research to provide a comprehensive look at the past, present, and future of AMD treatment.

• Dr. Patricia A. D’Amore
  Affiliation: Charles L. Schepens Professor of Ophthalmology at Harvard Medical School; Leader at Mass Eye and Ear.
  Expertise: A pioneer in vascular biology, her foundational work on angiogenesis paved the way for anti-VEGF therapies.
  Focus: Currently researching the pathogenesis of Age-Related Macular Degeneration (AMD).
  Accolades: Former President of ARVO and recipient of the António Champalimaud Award.
• Dr. Marco Zarbin
  Affiliation: Chair of the Institute of Ophthalmology and Visual Science at Rutgers New Jersey Medical School.
  Expertise: A world-renowned specialist in vitreoretinal surgery and clinical AMD management.
  Leadership: Past President of the American Ophthalmological Society; recipient of the AAO Life Achievement Award.
  Contribution: Brings a deep surgical and clinical perspective backed by over 250 peer-reviewed publications.
• Dr. Kapil Bharti
  Affiliation: Scientific Director of the National Eye Institute (NEI) Intramural Research Program.
  Expertise: A leader in regenerative medicine and stem cell-based therapies.
  Innovation: Initiated the first U.S. clinical trial for autologous iPSC-derived RPE patches and holds 18 patents.
  Focus: Translating laboratory discoveries into cell-based and drug-based treatments for retinal degeneration.

This webinar is sponsored by Johnson & Johnson.

Use the form below to register: